Hirofumi Okubo

Tokyo Medical University, The University of Osaka

Papers

2

Total Citations

63

H-Index

2

About

Dr. Hirofumi Okubo is a pioneering figure in urologic oncology and radiation therapy physics, whose work bridges surgical innovation and precision dosimetry. His most impactful contribution, a 2012 prospective comparison of robot-assisted radical cystectomy (RARC) versus open radical cystectomy (ORC) in Japan, has garnered 52 citations and stands as a landmark study in minimally invasive urologic surgery. By demonstrating the perioperative and pathologic outcomes of RARC performed by a single surgeon, Dr. Okubo provided critical evidence supporting the adoption of robotic techniques for bladder cancer treatment in a region where such data were previously absent. In parallel, his 2016 investigation into dose verification for CyberKnife® radiosurgery introduced the novel "potential error" (PE) concept, offering a robust measurement point for quality assurance in stereotactic radiation therapy. This work, though less cited, reflects his commitment to enhancing treatment accuracy and patient safety. Dr. Okubo’s dual expertise—advancing surgical robotics and refining radiation physics—positions him as a versatile researcher whose work continues to shape clinical practice in oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
63
Total Citations
32
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Versus Open Radical Cystectomy: Prospective Comparison of Perioperative and Pathologic Outcomes in Japan
52 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 20
🏛 Institutions: Tokyo Medical University, The University of Osaka

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago